Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PWWP domain-containing DNA repair factor 3A (PWWP3A) is a chromatin-associated protein characterized by the presence of a PWWP domain, which enables recognition of methylated histone H3 lysine 36 (H3K36me2/3) marks[6]. PWWP3A facilitates the maintenance and remodeling of chromatin architecture, especially in response to DNA damage[1][5][7]. It is rapidly recruited to sites of DNA breaks through interaction with the DNA repair protein TP53BP1, promoting localized chromatin relaxation and efficient repair, and is important for cell survival after genotoxic stress[3][4][5][7]. In animal studies, PWWP3A is highly expressed in the testis and is implicated in the aging-associated degeneration of this tissue, potentially due to defects in DNA repair or immune regulation[6]. There is no current evidence of targeting PWWP3A with clinical drugs, nor is it widely established as a biomarker or direct therapeutic target[1][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PWWP domain-containing DNA repair factor 3A (PWWP3A).